IPSEN (OTCMKTS:IPSEY) Shares Gap Up – Time to Buy?

IPSEN (OTCMKTS:IPSEY)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $46.30, but opened at $48.54. IPSEN shares last traded at $48.54, with a volume of 1,217 shares.

Wall Street Analyst Weigh In

A number of research firms have recently commented on IPSEY. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of IPSEN in a report on Tuesday, February 17th. UBS Group cut IPSEN from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 8th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

IPSEN Price Performance

The firm has a fifty day moving average of $43.92 and a 200 day moving average of $38.39.

IPSEN Company Profile

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).